relationship between the latter data and the pH values; this is
shown in Fig. 3c.
treatment with CF3COOH removed the tert-butyl protecting groups
and reaction with GdCl3 in water at pH 7 led to the isolation of the
neutral complex.
A further increase in the sensitivity of the pH assessment can
1
be obtained from acquiring the T1-weighted H-MR image at
y The 19F-containing reporter has been synthesized from the
alkylation of 1-adamantamine by 4[(2,3-epoxy)propyloxy]phenylacetic
acid phenyl methyl ester (CH3CN, DIPEA, 5 days at 50 1C), obtained
from the reaction of benzyl 4-hydroxybenzoate with epibromohydrin
(DMF, K2CO3, 6 hours at 70 1C). Cleavage of the benzyl group has
been achieved by hydrogenation with Pd/C at atmospheric pressure
to yield the carboxylic acid, that has been coupled to 2,20,200-trifluoro-
ethylamine (DMF, DIPEA, HBTU, 16 hours at RT). The final
product has been carefully purified to 4 98% by liquid chromato-
graphy on Amberchroms CG161 resin.
1 T where the relaxivity gap between q = 2 and q = 0
conditions is maximized (Fig. 3d).
In summary, the proof of concept reported here shows that
a novel, highly accurate pH mapping can be pursued by MRI
using the heteronuclear 19F signal to normalize the relaxation
enhancement values induced by a pH-responsive Gd-complex.
Moreover, the use of poly-b-CD as a macromolecular carrier
can be further exploited to host analogous adamantane
functionalized moieties to endow the supramolecular adduct
with targeting as well as multimodal capabilities.
z Magnetic resonance images have been acquired on a Bruker
Avance300 spectrometer operating at 7.1
T equipped with a
microimaging probe and on an Aspect scanner (Netanya, Israel)
operating at 1 T using standard T1-weighted multislice multiecho
sequences.
For an in vivo translation of the proposed method, it
appears necessary to improve the binding affinity of the
adamantane functionalized Gd-complex to the poly-b-CD
substrate. The system used here shows a good binding to
HSA (KA = 13 000 Mꢁ1). Thus, at the physiological protein
concentration of 0.6 mM and a 1 mM Gd-complex concentration
(and poly-b-CD and 19F-reporter in the above established
ratio), ca. 20% of the paramagnetic complex will be bound
to HSA.
1 M. P. Lowe, D. Parker, O. Reany, S. Aime, M. Botta,
G. Castellano, E. Gianolio and R. Pagliarin, J. Am. Chem. Soc.,
2001, 123, 7601.
2 S. R. Zhang, K. C. Wu and A. D. Sherry, Angew. Chem., Int. Ed.,
1999, 38, 3192.
3 S. Aime, M. Botta, S. Geninatti, G. B. Giovenzana, G. Palmisano
and M. Sisti, Chem. Commun., 1999, 1577.
4 S. Aime, A. Barge, M. Botta, J. A. K. Howard, R. Kataky,
M. P. Lowe, J. M. Moloney, D. Parker and A. De Sousa, Chem.
Commun., 1999, 1047.
5 R. Hovland, C. Glogard, A. J. Aasen and J. Klaveness, J. Chem.
Soc., Perkin Trans. 2, 2001, 929.
6 M. Woods, S. Zhang, E. Von Howard and A. D. Sherry,
Chem.–Eur. J., 2003, 9, 4634.
Finally, as it is known that in Gd-DO3A derivatives,z the
two inner sphere water molecules can be replaced by the
coordination of endogenous oxoanions,1,16,17 an improvement
in the design of the pH-responsive coordination cage should be
pursued. It has already been shown that the introduction of
carboxyalkyl substituents on the acetate arms inhibits anion
binding while maintaining the pH responsiveness.1,18
Economic and scientific support from MIUR (FIRB
RBI P06293N_001 and PRIN 2007W7M4NF projects),
EC-FP6-projects DiMI (LSHB-CT- 2005-512146), EMIL
(LSHC-CT-2004-503569), MEDITRANS (Targeted Delivery
of Nanomedicine: NMP4-CT-2006-026668), ENCITE
(European Network for ‘‘Cell Imaging and Tracking
Expertise’’ 201842) and EU-COST D38 Action is gratefully
acknowledged.
7 S. Aime, A. Barge, D. Delli Castelli, F. Fedeli, A. Mortillaro,
F. U. Nielsen and E. Terreno, Magn. Reson. Med., 2002, 47, 639.
8 J. A. Pikkemaat, R. T. Wegh, R. Lamerichs, R. A. van de
Molengraaf, S. Langereis, D. Burdinski, A. Y. F. Raymond,
H. M. Janssen, B. M. F. de Waal, N. P. Willard, E. W. Meijer
and H. Grull, Contrast Media Mol. Imaging, 2007, 2, 229.
9 M. Oishi, S. Sumitani and Y. Nagasaki, Bioconjugate Chem., 2007,
18, 1379.
10 A. M. Kenwright, I. Kuprov, E. De Luca, D. Parker, S. U. Pandya,
P. K. Senanayake and D. G. Smith, Chem. Commun., 2008, 2514.
11 S. Aime, F. Fedeli, A. Sanino and E. Terreno, J. Am. Chem. Soc.,
2006, 128, 11326.
12 N. Raghunand, C. Howison, A. D. Sherry, S. R. Zhang and
R. J. Gillies, Magn. Reson. Med., 2003, 49, 249.
13 M. L. Garcia-Martin, G. V. Martinez, N. Raghunand,
A. D. Sherry, S. R. Zhang and R. J. Gillies, Magn. Reson. Med.,
2006, 55, 309.
Notes and references
14 J. Carrazana, A. Jover, F. Meijide, V. H. Soto and J. Vasquez
Tato, J. Phys. Chem. B, 2005, 109, 9719.
z The synthesis of the ligand involved alkylation of the DO3A–
tris-tert-butylester with N-(benzyloxycarbonyl)-2-bromoethylamine
(CH3CN, K2CO3, 4 days at 50 1C). Following chromatographic
purification on silica, cleavage of the benzyloxycarbonyl group
has been achieved by hydrogenation with Pd/C at atmospheric
pressure to yield the free primary amino group. This group allowed
the subsequent coupling with 4-(methyloxycarbonylmethylenoxy)-
benzenesulfonyl chloride (CH3CN, triethylamine, 3 days at RT),
obtained by reaction of methyl phenoxyacetate with chlorosulfonic
acid in dichloromethane. After purification by chromatography on
silica and hydrolysis of the methyl ester (MeOH–H2O, pH 12, 1 hour),
the carboxylic acid was coupled with 1-adamantamine (DMF, HATU,
20 hours at RT). Following chromatographic purification on silica,
15 S. Aime, M. Botta, M. Fasano and E. Terreno, in The chemistry of
Contrast Agents, ed. A. Merbach and E. Toth, John Wiley & Sons,
Chichester, UK, 2001, pp. 193–241.
16 E. Terreno, M. Botta, P. Boniforte, C. Bracco, L. Milone,
B. Mondino, F. Uggeri and S. Aime, Chem.–Eur. J., 2005, 11,
5531.
17 S. Aime, E. Gianolio, E. Terreno, G. B. Giovenzana, R. Pagliarin,
M. Sisti, G. Palmisano, M. Botta, M. P. Lowe and D. Parker,
J. Biol. Inorg. Chem., 2000, 5, 488.
18 J. I. Bruce, R. S. Dickins, L. J. Govenlock, T. Gunnlaugsson,
S. Lopinski, M. P. Lowe, D. Parker, R. D. Peacock, J. J. B. Perry,
S. Aime and M. Botta, J. Am. Chem. Soc., 2000, 122, 9674.
ꢀc
This journal is The Royal Society of Chemistry 2009
6046 | Chem. Commun., 2009, 6044–6046